Regulation of tumor suppressor p53 at the RNA level

Journal of Molecular Medicine

Volumn 88, Issue 7, 2010, Pages 645-652

  Vilborg, Anna ^a   Wilhelm, Margareta T ^a   Wiman, Klas G ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

AU rich elements; miRNA; mRNA regulation; p53; Wig 1

Indexed keywords

ANTAGOMIR; ANTIGEN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; HUMAN ANTIGEN R; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MICRORNA; PROTEIN; PROTEIN BAX; PROTEIN MDM2; PROTEIN NOXA; PROTEIN P53; PUMA PROTEIN; QUERCETIN; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WIG 1 PROTEIN; 3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; APOPTOSIS; AU RICH ELEMENT; CANCER THERAPY; CELL AGING; CELL DEATH; CELL STRESS; CELL SURVIVAL; CIS ISOMER; CYTOPLASM; DNA DAMAGE; DNA REPLICATION; GENE ACTIVATION; GENE CONTROL; GENETIC TRANSCRIPTION; GENOTOXICITY; HUMAN; INTERNAL RIBOSOME ENTRY SITE; ONCOGENE; OPEN READING FRAME; PANCREAS ADENOCARCINOMA; POLYADENYLATION; POSITIVE FEEDBACK; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; REGULATORY MECHANISM; REGULATORY SEQUENCE; REVIEW; SIGNAL TRANSDUCTION; TRANSACTIVATION; TUMOR GROWTH; TURNOVER TIME; ULTRAVIOLET RADIATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; RNA STABILITY;

3' UNTRANSLATED REGIONS; 5' UNTRANSLATED REGIONS; BASE SEQUENCE; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; RNA STABILITY; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77954537044     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-010-0609-2     Document Type: Review

References (97)

1. P Hainaut KG Wiman 2009 30 years and a long way into p53 research Lancet Oncol 10 913 919 10.1016/S1470-2045(09)70198-6 19717093
2. J Bartkova Z Horejsi K Koed A Kramer F Tort K Zieger P Guldberg M Sehested JM Nesland C Lukas T Orntoft J Lukas J Bartek 2005 DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis Nature 434 864 870 10.1038/nature03482 1:CAS:528:DC%2BD2MXjtFOms7k%3D 15829956 (Pubitemid 40558993)
3. VG Gorgoulis H Pratsinis P Zacharatos C Demoliou F Sigala PJ Asimacopoulos AG Papavassiliou D Kletsas 2005 p53-dependent ICAM-1 overexpression in senescent human cells identified in atherosclerotic lesions Lab Invest 85 502 511 10.1038/labinvest.3700241 1:CAS:528:DC%2BD2MXisVShsL8%3D 15711569 (Pubitemid 40523942)
4. B Vogelstein D Lane AJ Levine 2000 Surfing the p53 network Nature 408 307 310 10.1038/35042675 1:CAS:528:DC%2BD3cXosVemtrY%3D 11099028
5. KH Vousden KM Ryan 2009 p53 and metabolism Nat Rev, Cancer 9 691 700 10.1038/nrc2715 1:CAS:528:DC%2BD1MXhtFentb%2FM
6. V Krizhanovsky SW Lowe 2009 Stem cells: the promises and perils of p53 Nature 460 1085 1086 10.1038/4601085a 10.1038/4601085a 1:CAS:528: DC%2BD1MXhtVGiurjK 19713919
7. KH Vousden X Lu 2002 Live or let die: the cell's response to p53 Nat Rev, Cancer 2 594 604 10.1038/nrc864 10.1038/nrc864 1:CAS:528:DC%2BD38XlslGqsL8%3D (Pubitemid 37328926)
8. CJ Sherr JD Weber 2000 The ARF/p53 pathway Curr Opin Genet Dev 10 94 99 10.1016/S0959-437X(99)00038-6 1:CAS:528:DC%2BD3cXhslOks70%3D 10679383 S0959-437X(99)00038-6 [pii] (Pubitemid 30113711)
9. M Mihara S Erster A Zaika O Petrenko T Chittenden P Pancoska UM Moll 2003 p53 has a direct apoptogenic role at the mitochondria Mol Cell 11 577 590 10.1016/S1097-2765(03)00050-9 1:CAS:528:DC%2BD3sXjtVWktrk%3D 12667443 S1097276503000509 [pii] (Pubitemid 36385115)
10. JC Bourdon 2007 p53 Family isoforms Curr Pharm Biotechnol 8 332 336 10.2174/138920107783018444 1:CAS:528:DC%2BD1cXitVSms70%3D 18289041 (Pubitemid 350268191)
11. T Soussi KG Wiman 2007 Shaping genetic alterations in human cancer: the p53 mutation paradigm Cancer Cell 12 303 312 10.1016/j.ccr.2007.10.001 1:CAS:528:DC%2BD2sXht1ais7zN 17936556 (Pubitemid 47539312)
12. R Brosh V Rotter 2009 When mutants gain new powers: news from the mutant p53 field Nat Rev, Cancer 9 701 713 10.1038/nrc2693 1:CAS:528:DC%2BD1MXhtVWhsb7J
13. L Weisz A Damalas M Liontos P Karakaidos G Fontemaggi R Maor-Aloni M Kalis M Levrero S Strano VG Gorgoulis V Rotter G Blandino M Oren 2007 Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cells Cancer Res 67 2396 2401 10.1158/0008-5472.CAN-06-2425 10.1158/0008-5472.CAN-06-2425 1:CAS:528:DC%2BD2sXivV2gurw%3D 17363555 (Pubitemid 46548921)
14. KG Wiman 2006 Strategies for therapeutic targeting of the p53 pathway in cancer Cell Death Differ 13 921 926 10.1038/sj.cdd.4401921 1:CAS:528: DC%2BD28Xks1OrtbY%3D 16557267
15. W Xue L Zender C Miething RA Dickins E Hernando V Krizhanovsky C Cordon-Cardo SW Lowe 2007 Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas Nature 445 656 660 10.1038/nature05529 1:CAS:528:DC%2BD2sXhtlOrtbo%3D 17251933 (Pubitemid 46232886)
16. A Ventura DG Kirsch ME McLaughlin DA Tuveson J Grimm L Lintault J Newman EE Reczek R Weissleder T Jacks 2007 Restoration of p53 function leads to tumour regression in vivo Nature 445 661 665 10.1038/nature05541 1:CAS:528: DC%2BD2sXhtlOrtbg%3D 17251932 (Pubitemid 46232887)
17. A Vilborg JA Glahder MT Wilhelm C Bersani M Corcoran S Mahmoudi M Rosenstierne D Grander M Farnebo B Norrild KG Wiman 2009 The p53 target Wig-1 regulates p53 mRNA stability through an AU-rich element Proc Natl Acad Sci USA 106 15756 15761 10.1073/pnas.0900862106 1:CAS:528:DC%2BD1MXhtFyjsLbN 19805223
18. GT Bommer I Gerin Y Feng AJ Kaczorowski R Kuick RE Love Y Zhai TJ Giordano ZS Qin BB Moore OA MacDougald KR Cho ER Fearon 2007 p53-mediated activation of miRNA34 candidate tumor-suppressor genes Curr Biol 17 1298 1307 10.1016/j.cub.2007.06.068 1:CAS:528:DC%2BD2sXosF2ju7o%3D 17656095 (Pubitemid 47176893)
19. N Raver-Shapira E Marciano E Meiri Y Spector N Rosenfeld N Moskovits Z Bentwich M Oren 2007 Transcriptional activation of miR-34a contributes to p53-mediated apoptosis Mol Cell 26 731 743 10.1016/j.molcel.2007.05.017 1:CAS:528:DC%2BD2sXnt1Cqur0%3D 17540598 (Pubitemid 46856247)
20. V Tarasov P Jung B Verdoodt D Lodygin A Epanchintsev A Menssen G Meister H Hermeking 2007 Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest Cell Cycle 6 1586 1593 1:CAS:528:DC%2BD2sXhtFWlsr3O 17554199
21. L He X He LP Lim E de Stanchina Z Xuan Y Liang W Xue L Zender J Magnus D Ridzon AL Jackson PS Linsley C Chen SW Lowe MA Cleary GJ Hannon 2007 A microRNA component of the p53 tumour suppressor network Nature 447 1130 1134 10.1038/nature05939 1:CAS:528:DC%2BD2sXmvFKmu7c%3D 17554337 (Pubitemid 47014436)
22. DC Corney A Flesken-Nikitin AK Godwin W Wang AY Nikitin 2007 MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth Cancer Res 67 8433 8438 10.1158/0008-5472.CAN-07-1585 1:CAS:528:DC%2BD2sXhtVCit7%2FF 17823410 (Pubitemid 47437414)
23. A Mirza Q Wu L Wang T McClanahan WR Bishop F Gheyas W Ding B Hutchins T Hockenberry P Kirschmeier JR Greene S Liu 2003 Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression Oncogene 22 3645 3654 10.1038/sj.onc.1206477 10.1038/sj.onc.1206477 1:CAS:528:DC%2BD3sXktlSjtrs%3D 12789273 (Pubitemid 36765324)
24. HL Yan G Xue Q Mei YZ Wang FX Ding MF Liu MH Lu Y Tang HY Yu SH Sun 2009 Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis EMBO J 28 2719 2732 10.1038/emboj.2009.214 1:CAS:528:DC%2BD1MXpvFCktbg%3D 19696742
25. R Mudhasani Z Zhu G Hutvagner CM Eischen S Lyle LL Hall JB Lawrence AN Imbalzano SN Jones 2008 Loss of miRNA biogenesis induces p19Arf-p53 signaling and senescence in primary cells J Cell Biol 181 1055 1063 10.1083/jcb.200802105 1:CAS:528:DC%2BD1cXotF2itrg%3D 18591425 (Pubitemid 351915481)
26. HI Suzuki K Yamagata K Sugimoto T Iwamoto S Kato K Miyazono 2009 Modulation of microRNA processing by p53 Nature 460 529 533 10.1038/nature08199 1:CAS:528:DC%2BD1MXovFymtL0%3D 19626115
27. J Mosner T Mummenbrauer C Bauer G Sczakiel F Grosse W Deppert 1995 Negative feedback regulation of wild-type p53 biosynthesis EMBO J 14 4442 4449 1:CAS:528:DyaK2MXovVektrw%3D 7556087
28. SJ Miller T Suthiphongchai GP Zambetti ME Ewen 2000 p53 binds selectively to the 5′ untranslated region of cdk4, an RNA element necessary and sufficient for transforming growth factor beta- and p53-mediated translational inhibition of cdk4 Mol Cell Biol 20 8420 8431 10.1128/MCB.20.22.8420-8431.2000 1:CAS:528:DC%2BD3cXotFWrt7c%3D 11046139
29. IG Gonzalez-Herrera L Prado-Lourenco S Teshima-Kondo K Kondo F Cabon JF Arnal F Bayard AC Prats 2006 IRES-dependent regulation of FGF-2 mRNA translation in pathophysiological conditions in the mouse Biochem Soc Trans 34 17 21 10.1042/BST0340017 1:CAS:528:DC%2BD2MXhtFCqsLfN 16246170
30. B Galy L Creancier L Prado-Lourenco AC Prats H Prats 2001 p53 directs conformational change and translation initiation blockade of human fibroblast growth factor 2 mRNA Oncogene 20 4613 4620 10.1038/sj.onc.1204630 1:CAS:528:DC%2BD3MXmtFejs7Y%3D 11498784 (Pubitemid 32762433)
31. KH Vousden C Prives 2009 Blinded by the light: the growing complexity of p53 Cell 137 413 431 10.1016/j.cell.2009.04.037 10.1016/j.cell.2009.04.037 1:CAS:528:DC%2BD1MXlvFams74%3D 19410540
32. MB Kastan O Onyekwere D Sidransky B Vogelstein RW Craig 1991 Participation of p53 protein in the cellular response to DNA damage Cancer Res 51 6304 6311 1:CAS:528:DyaK38XhvFSltg%3D%3D 1933891
33. M Takagi MJ Absalon KG McLure MB Kastan 2005 Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin Cell 123 49 63 10.1016/j.cell.2005.07.034 1:CAS:528:DC%2BD2MXhtFelt7nF 16213212 (Pubitemid 41414528)
34. DQ Yang MJ Halaby Y Zhang 2006 The identification of an internal ribosomal entry site in the 5′-untranslated region of p53 mRNA provides a novel mechanism for the regulation of its translation following DNA damage Oncogene 25 4613 4619 10.1038/sj.onc.1209483 1:CAS:528:DC%2BD28Xnsl2jsb8%3D 16607284 (Pubitemid 44175120)
35. H Liu ZG Lu Y Miki K Yoshida 2007 Protein kinase C delta induces transcription of the TP53 tumor suppressor gene by controlling death-promoting factor Btf in the apoptotic response to DNA damage Mol Cell Biol 27 8480 8491 10.1128/MCB.01126-07 1:CAS:528:DC%2BD1cXmt1eqtw%3D%3D 17938203
36. V Raman SA Martensen D Reisman E Evron WF Odenwald E Jaffee J Marks S Sukumar 2000 Compromised HOXA5 function can limit p53 expression in human breast tumours Nature 405 974 978 10.1038/35016125 1:CAS:528:DC%2BD3cXks1WktLg%3D 10879542 (Pubitemid 30435057)
37. RT Phan R Dalla-Favera 2004 The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells Nature 432 635 639 10.1038/nature03147 10.1038/nature03147 1:CAS:528:DC%2BD2cXhtVeht7rE 15577913 (Pubitemid 39626271)
38. CJ Lynch J Milner 2006 Loss of one p53 allele results in four-fold reduction of p53 mRNA and protein: a basis for p53 haplo-insufficiency Oncogene 25 3463 3470 10.1038/sj.onc.1209387 1:CAS:528:DC%2BD28XlsVersbs%3D 16449974 (Pubitemid 43877049)
39. R Grover MM Candeias R Fahraeus S Das 2009 p53 and little brother p53/47: linking IRES activities with protein functions Oncogene 28 2766 2772 10.1038/onc.2009.138 1:CAS:528:DC%2BD1MXms1aksr8%3D 19483723
40. Y Ofir-Rosenfeld K Boggs D Michael MB Kastan M Oren 2008 Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26 Mol Cell 32 180 189 10.1016/j.molcel.2008.08.031 1:CAS:528:DC%2BD1cXhtlehsb3K 18951086
41. H Kim S You LK Foster J Farris DN Foster 2001 The rapid destabilization of p53 mRNA in immortal chicken embryo fibroblast cells Oncogene 20 5118 5123 10.1038/sj.onc.1204664 1:CAS:528:DC%2BD3MXmslGmu74%3D 11526500 (Pubitemid 32844040)
42. S Mahmoudi S Henriksson M Corcoran C Mendez-Vidal KG Wiman M Farnebo 2009 Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage Mol Cell 33 462 471 10.1016/j.molcel.2009.01.028 1:CAS:528: DC%2BD1MXltFSnu70%3D 19250907
43. MM Candeias L Malbert-Colas DJ Powell C Daskalogianni MM Maslon N Naski K Bourougaa F Calvo R Fahraeus 2008 p53 mRNA controls p53 activity by managing Mdm2 functions Nat Cell Biol 10 1098 1105 10.1038/ncb1770 1:CAS:528: DC%2BD1cXhtVGgtLbK 19160491
44. P Brodersen O Voinnet 2009 Revisiting the principles of microRNA target recognition and mode of action Nat Rev 10 141 148 10.1038/nrm2619 1:CAS:528:DC%2BD1MXltFWqtg%3D%3D
45. M Ghildiyal PD Zamore 2009 Small silencing RNAs: an expanding universe Nat Rev, Genet 10 94 108 10.1038/nrg2504 1:CAS:528:DC%2BD1MXlvFChtA%3D%3D
46. MT Le C Teh N Shyh-Chang H Xie B Zhou V Korzh HF Lodish B Lim 2009 MicroRNA-125b is a novel negative regulator of p53 Genes Dev 23 862 876 10.1101/gad.1767609 1:CAS:528:DC%2BD1MXks1Sruro%3D 19293287
47. Y Zhang JS Gao X Tang LD Tucker P Quesenberry I Rigoutsos B Ramratnam 2009 MicroRNA 125a and its regulation of the p53 tumor suppressor gene FEBS Lett 583 3725 3730 10.1016/j.febslet.2009.10.002 1:CAS:528:DC%2BD1MXhsVWls7vN 19818772
48. B Schumacher M Hanazawa MH Lee S Nayak K Volkmann ER Hofmann M Hengartner T Schedl A Gartner 2005 Translational repression of Caenorhabditis elegans p53 by GLD-1 regulates DNA damage-induced apoptosis Cell 120 357 368 10.1016/j.cell.2004.12.009 1:CAS:528:DC%2BD2MXhs1Krt78%3D 15707894 (Pubitemid 40222430)
49. J Hausser M Landthaler L Jaskiewicz D Gaidatzis M Zavolan 2009 Relative contribution of sequence and structure features to the mRNA binding of Argonaute/EIF2C-miRNA complexes and the degradation of miRNA targets Genome Res 19 2009 2020 10.1101/gr.091181.109 1:CAS:528:DC%2BD1MXhsVSmtLnI 19767416
50. A Grimson KK Farh WK Johnston P Garrett-Engele LP Lim DP Bartel 2007 MicroRNA targeting specificity in mammals: determinants beyond seed pairing Mol Cell 27 91 105 10.1016/j.molcel.2007.06.017 10.1016/j.molcel.2007.06.017 1:CAS:528:DC%2BD2sXot1els7Y%3D 17612493 (Pubitemid 46991392)
51. C Barreau L Paillard HB Osborne 2005 AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res 33 7138 7150 10.1093/nar/gki1012 10.1093/nar/gki1012 1:CAS:528:DC%2BD28XisFKqsA%3D%3D 16391004 (Pubitemid 43125082)
52. Y Audic RS Hartley 2004 Post-transcriptional regulation in cancer Biol Cell 96 479 498 10.1016/j.biolcel.2004.05.002 10.1016/j.biolcel.2004.05.002 1:CAS:528:DC%2BD2cXnslGjuro%3D 15380615
53. K Mazan-Mamczarz S Galban I Lopez de Silanes JL Martindale U Atasoy JD Keene M Gorospe 2003 RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation Proc Natl Acad Sci USA 100 8354 8359 10.1073/pnas.1432104100 10.1073/pnas.1432104100 1:CAS:528:DC%2BD3sXlsFGnt7g%3D 12821781 (Pubitemid 36842549)
54. S Galban JL Martindale K Mazan-Mamczarz I Lopez de Silanes J Fan W Wang J Decker M Gorospe 2003 Influence of the RNA-binding protein HuR in pVHL-regulated p53 expression in renal carcinoma cells Mol Cell Biol 23 7083 7095 10.1128/MCB.23.20.7083-7095.2003 1:CAS:528:DC%2BD3sXotVSrtb0%3D 14517280 (Pubitemid 37210992)
55. L Fu W Ma S Benchimol 1999 A translation repressor element resides in the 3′ untranslated region of human p53 mRNA Oncogene 18 6419 6424 10.1038/sj.onc.1203064 1:CAS:528:DyaK1MXnvFyhsro%3D 10597243
56. T Zou K Mazan-Mamczarz JN Rao L Liu BS Marasa AH Zhang L Xiao R Pullmann M Gorospe JY Wang 2006 Polyamine depletion increases cytoplasmic levels of RNA-binding protein HuR leading to stabilization of nucleophosmin and p53 mRNAs J Biol Chem 281 19387 19394 10.1074/jbc.M602344200 10.1074/jbc.M602344200 1:CAS:528:DC%2BD28Xms1Gqs78%3D 16690610 (Pubitemid 44035444)
57. X Tong JC Pelling 2009 Enhancement of p53 expression in keratinocytes by the bioflavonoid apigenin is associated with RNA-binding protein HuR Mol Carcinog 48 118 129 10.1002/mc.20460 1:CAS:528:DC%2BD1MXitlClsL4%3D 18680106
58. M Ghosh HL Aguila J Michaud Y Ai MT Wu A Hemmes A Ristimaki C Guo H Furneaux T Hla 2009 Essential role of the RNA-binding protein HuR in progenitor cell survival in mice J Clin Invest 119 3530 3543 1:CAS:528:DC%2BD1MXhsFCit7jM 19884656
59. S Varmeh-Ziaie I Okan Y Wang KP Magnusson P Warthoe M Strauss KG Wiman 1997 Wig-1, a new p53-induced gene encoding a zinc finger protein Oncogene 15 2699 2704 10.1038/sj.onc.1201454 10.1038/sj.onc.1201454 1:CAS:528: DyaK2sXotVWnsLs%3D 9400996
60. F Hellborg W Qian C Mendez-Vidal C Asker M Kost-Alimova M Wilhelm S Imreh KG Wiman 2001 Human wig-1, a p53 target gene that encodes a growth inhibitory zinc finger protein Oncogene 20 5466 5474 10.1038/sj.onc.1204722 10.1038/sj.onc.1204722 1:CAS:528:DC%2BD3MXntFWjsb8%3D 11571644 (Pubitemid 32889483)
61. D Israeli E Tessler Y Haupt A Elkeles S Wilder R Amson A Telerman M Oren 1997 A novel p53-inducible gene, PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis EMBO J 16 4384 4392 10.1093/emboj/16.14. 4384 10.1093/emboj/16.14.4384 1:CAS:528:DyaK2sXkvFeqtbg%3D 9250682 (Pubitemid 27298191)
62. C Mendez-Vidal MT Wilhelm F Hellborg W Qian KG Wiman 2002 The p53-induced mouse zinc finger protein wig-1 binds double-stranded RNA with high affinity Nucleic Acids Res 30 1991 1996 10.1093/nar/30.9.1991 1:CAS:528: DC%2BD38XktFGhtbY%3D 11972337
63. F Hellborg KG Wiman 2004 The p53-induced Wig-1 zinc finger protein is highly conserved from fish to man Int J Oncol 24 1559 1564 1:CAS:528: DC%2BD2cXkvFaisLg%3D 15138600
64. C Mendez Vidal M Prahl KG Wiman 2006 The p53-induced Wig-1 protein binds double-stranded RNAs with structural characteristics of siRNAs and miRNAs FEBS Lett 580 4401 4408 10.1016/j.febslet.2006.07.005 10.1016/j.febslet.2006.07.005 1:CAS:528:DC%2BD28Xns12lsLg%3D 16844115 (Pubitemid 44118258)
65. T Nakajima C Uchida SF Anderson CG Lee J Hurwitz JD Parvin M Montminy 1997 RNA helicase A mediates association of CBP with RNA polymerase II Cell 90 1107 1112 10.1016/S0092-8674(00)80376-1 1:CAS:528:DyaK2sXmtlOmurY%3D 9323138 (Pubitemid 27408524)
66. SF Anderson BP Schlegel T Nakajima ES Wolpin JD Parvin 1998 BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A Nat Genet 19 254 256 10.1038/930 1:CAS:528:DyaK1cXls1SnsL4%3D 9662397 (Pubitemid 28309336)
67. T Tetsuka H Uranishi T Sanda K Asamitsu JP Yang F Wong-Staal T Okamoto 2004 RNA helicase A interacts with nuclear factor kappaB p65 and functions as a transcriptional coactivator Eur J Biochem 271 3741 3751 10.1111/j.1432-1033. 2004.04314.x 1:CAS:528:DC%2BD2cXnvVWms7g%3D 15355351 (Pubitemid 39233616)
68. TR Hartman S Qian C Bolinger S Fernandez DR Schoenberg K Boris-Lawrie 2006 RNA helicase A is necessary for translation of selected messenger RNAs Nat Struct Mol Biol 13 509 516 10.1038/nsmb1092 1:CAS:528:DC%2BD28Xlt1yntLg%3D 16680162 (Pubitemid 43848905)
69. M Fahling R Mrowka A Steege P Martinka PB Persson BJ Thiele 2006 Heterogeneous nuclear ribonucleoprotein-A2/B1 modulate collagen prolyl 4-hydroxylase, alpha (I) mRNA stability J Biol Chem 281 9279 9286 10.1074/jbc.M510925200 10.1074/jbc.M510925200 16464861 (Pubitemid 43864643)
70. M Asanuma I Miyazaki Y Higashi FJ Diaz-Corrales M Shimizu K Miyoshi N Ogawa 2007 Suppression of p53-activated gene, PAG608, attenuates methamphetamine-induced neurotoxicity Neurosci Lett 414 263 267 10.1016/j.neulet.2006.12.036 10.1016/j.neulet.2006.12.036 1:CAS:528: DC%2BD2sXitl2js7Y%3D 17234339
71. RA Steinman 2007 mRNA stability control: a clandestine force in normal and malignant hematopoiesis Leukemia 21 1158 1171 10.1038/sj.leu.2404656 10.1038/sj.leu.2404656 1:CAS:528:DC%2BD2sXlsFOhsrg%3D 17392821 (Pubitemid 46838514)
72. LB Nabors GY Gillespie L Harkins PH King 2001 HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3′ untranslated regions of cytokine and angiogenic factor mRNAs Cancer Res 61 2154 2161 1:CAS:528:DC%2BD3MXit1Ogsbs%3D 11280780
73. LA Brosens JJ Keller L Pohjola C Haglund FH Morsink C Iacobuzio-Donahue M Goggins FM Giardiello A Ristimaki GJ Offerhaus 2008 Increased expression of cytoplasmic HuR in familial adenomatous polyposis Cancer Biol Ther 7 424 427 18094611
74. C Denkert I Koch N von Keyserlingk A Noske S Niesporek M Dietel W Weichert 2006 Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2 Mod Pathol 19 1261 1269 10.1038/modpathol.3800645 1:CAS:528:DC%2BD28XotlCgu74%3D 16799479 (Pubitemid 44268197)
75. C Denkert W Weichert KJ Winzer BM Muller A Noske S Niesporek G Kristiansen H Guski M Dietel S Hauptmann 2004 Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma Clin Cancer Res 10 5580 5586 10.1158/1078-0432.CCR-04-0070 1:CAS:528:DC%2BD2cXmvFSlur0%3D 15328200 (Pubitemid 39100499)
76. G Stoecklin P Stoeckle M Lu O Muehlemann C Moroni 2001 Cellular mutants define a common mRNA degradation pathway targeting cytokine AU-rich elements RNA 7 1578 1588 1:CAS:528:DC%2BD3MXos1Khu78%3D 11720287
77. SE Brennan Y Kuwano N Alkharouf PJ Blackshear M Gorospe GM Wilson 2009 The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis Cancer Res 69 5168 5176 10.1158/0008-5472.CAN-08-4238 1:CAS:528:DC%2BD1MXnt1equ74%3D 19491267
78. X Yang W Wang J Fan A Lal D Yang H Cheng M Gorospe 2004 Prostaglandin A2-mediated stabilization of p21 mRNA through an ERK-dependent pathway requiring the RNA-binding protein HuR J Biol Chem 279 49298 49306 10.1074/jbc.M407535200 10.1074/jbc.M407535200 1:CAS:528:DC%2BD2cXpslKis7g%3D 15371446 (Pubitemid 39625816)
79. MJ Chae HY Sung EH Kim M Lee H Kwak CH Chae S Kim WY Park 2009 Chemical inhibitors destabilize HuR binding to the AU-rich element of TNF-alpha mRNA Exp Mol Med 41 824 831 10.3858/emm.2009.41.11.088 1:CAS:528:DC%2BD1MXhsFGqur%2FE 19949288
80. K Shimoi S Masuda M Furugori S Esaki N Kinae 1994 Radioprotective effect of antioxidative flavonoids in gamma-ray irradiated mice Carcinogenesis 15 2669 2672 10.1093/carcin/15.11.2669 1:CAS:528:DyaK2MXitFyrsrw%3D 7955124
81. M Bloomston WL Frankel F Petrocca S Volinia H Alder JP Hagan CG Liu D Bhatt C Taccioli CM Croce 2007 MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis JAMA 297 1901 1908 10.1001/jama.297.17.1901 1:CAS:528:DC%2BD2sXkvFKru7g%3D 17473300 (Pubitemid 46707844)
82. M Bousquet C Quelen R Rosati V Mansat-De Mas R La Starza C Bastard E Lippert P Talmant M Lafage-Pochitaloff D Leroux C Gervais F Viguie JL Lai C Terre B Beverlo C Sambani A Hagemeijer P Marynen G Delsol N Dastugue C Mecucci P Brousset 2008 Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation J Exp Med 205 2499 2506 10.1084/jem.20080285 1:CAS:528: DC%2BD1cXhtlWnt7fL 18936236
83. XB Shi L Xue J Yang AH Ma J Zhao M Xu CG Tepper CP Evans HJ Kung RW deVere White 2007 An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells Proc Natl Acad Sci USA 104 19983 19988 10.1073/pnas.0706641104 1:CAS:528:DC%2BD1cXhs1WmtA%3D%3D 18056640
84. PT Nelson DA Baldwin WP Kloosterman S Kauppinen RH Plasterk Z Mourelatos 2006 RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain RNA 12 187 191 10.1261/rna.2258506 1:CAS:528:DC%2BD28XhtlSjsrw%3D 16373485 (Pubitemid 43121922)
85. GA Calin CG Liu C Sevignani M Ferracin N Felli CD Dumitru M Shimizu A Cimmino S Zupo M Dono ML Dell'Aquila H Alder L Rassenti TJ Kipps F Bullrich M Negrini CM Croce 2004 MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias Proc Natl Acad Sci USA 101 11755 11760 10.1073/pnas.0404432101 1:CAS:528:DC%2BD2cXntVersro%3D 15284443 (Pubitemid 39095368)
86. R Versteeg H Caron NC Cheng P van der Drift R Slater A Westerveld PA Voute O Delattre G Laureys N Van Roy, et al. 1995 1p36: every subband a suppressor? Eur J Cancer 31A 538 541 10.1016/0959-8049(95)00037-J 1:CAS:528:DyaK2MXms12ksLY%3D 7576962
87. C Welch Y Chen RL Stallings 2007 MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells Oncogene 26 5017 5022 10.1038/sj.onc.1210293 10.1038/sj.onc.1210293 1:CAS:528: DC%2BD2sXotFygs78%3D 17297439 (Pubitemid 47172643)
88. A Gaur DA Jewell Y Liang D Ridzon JH Moore C Chen VR Ambros MA Israel 2007 Characterization of microRNA expression levels and their biological correlates in human cancer cell lines Cancer Res 67 2456 2468 10.1158/0008-5472.CAN-06-2698 10.1158/0008-5472.CAN-06-2698 1:CAS:528: DC%2BD2sXivV2gu78%3D 17363563 (Pubitemid 46548930)
89. E Beaudoing D Gautheret 2001 Identification of alternate polyadenylation sites and analysis of their tissue distribution using EST data Genome Res 11 1520 1526 10.1101/gr.190501 1:CAS:528:DC%2BD3MXmvV2mtrs%3D 11544195 (Pubitemid 32894677)
90. H Zhang JY Lee B Tian 2005 Biased alternative polyadenylation in human tissues Genome Biol 6 R100 10.1186/gb-2005-6-12-r100 16356263
91. R Sandberg JR Neilson A Sarma PA Sharp CB Burge 2008 Proliferating cells express mRNAs with shortened 3′ untranslated regions and fewer microRNA target sites Science 320 1643 1647 10.1126/science.1155390 1:CAS:528: DC%2BD1cXnt1Oju70%3D 18566288 (Pubitemid 351931255)
92. C Mayr DP Bartel 2009 Widespread shortening of 3′UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells Cell 138 673 684 10.1016/j.cell.2009.06.016 1:CAS:528:DC%2BD1MXhsVCjs7rM 19703394
93. Z Ji JY Lee Z Pan B Jiang B Tian 2009 Progressive lengthening of 3′ untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development Proc Natl Acad Sci USA 106 7028 7033 10.1073/pnas. 0900028106 1:CAS:528:DC%2BD1MXlvFSgtrw%3D 19372383
94. J Lu G Getz EA Miska E Alvarez-Saavedra J Lamb D Peck A Sweet-Cordero BL Ebert RH Mak AA Ferrando JR Downing T Jacks HR Horvitz TR Golub 2005 MicroRNA expression profiles classify human cancers Nature 435 834 838 10.1038/nature03702 1:CAS:528:DC%2BD2MXkvVGgsLc%3D 15944708 (Pubitemid 40839735)
95. MS Kumar J Lu KL Mercer TR Golub T Jacks 2007 Impaired microRNA processing enhances cellular transformation and tumorigenesis Nat Genet 39 673 677 10.1038/ng2003 1:CAS:528:DC%2BD2sXksFersLo%3D 17401365 (Pubitemid 46676103)
96. SP Tuck L Crawford 1989 Characterization of the human p53 gene promoter Mol Cell Biol 9 2163 2172 1:CAS:528:DyaL1MXit1Kntbw%3D 2664471
97. PS Ray R Grover S Das 2006 Two internal ribosome entry sites mediate the translation of p53 isoforms EMBO Rep 7 404 410 10.1038/sj.embor.7400623 1:CAS:528:DC%2BD28XjtV2htL0%3D 16440000